Logo image of ETOR

ETORO GROUP LTD-A (ETOR) Stock Fundamental Analysis

NASDAQ:ETOR - Nasdaq - VGG320891077 - Common Stock - Currency: USD

65.08  +1.32 (+2.07%)

After market: 65.5 +0.42 (+0.65%)

Fundamental Rating

4

Overall ETOR gets a fundamental rating of 4 out of 10. We evaluated ETOR against 236 industry peers in the Capital Markets industry. ETOR has a great financial health rating, but its profitability evaluates not so good. ETOR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ETOR had positive earnings in the past year.
ETOR Yearly Net Income VS EBIT VS OCF VS FCFETOR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

ETOR has a Return On Assets of 15.32%. This is amongst the best in the industry. ETOR outperforms 97.03% of its industry peers.
ETOR's Return On Equity of 21.50% is amongst the best of the industry. ETOR outperforms 89.83% of its industry peers.
Looking at the Return On Invested Capital, with a value of 20.02%, ETOR belongs to the top of the industry, outperforming 96.61% of the companies in the same industry.
Industry RankSector Rank
ROA 15.32%
ROE 21.5%
ROIC 20.02%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ETOR Yearly ROA, ROE, ROICETOR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2022 2023 2024 5 10 15 20

1.3 Margins

ETOR has a worse Profit Margin (1.52%) than 70.76% of its industry peers.
Looking at the Operating Margin, with a value of 2.26%, ETOR is doing worse than 71.61% of the companies in the same industry.
The Gross Margin of ETOR (6.52%) is worse than 70.76% of its industry peers.
Industry RankSector Rank
OM 2.26%
PM (TTM) 1.52%
GM 6.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ETOR Yearly Profit, Operating, Gross MarginsETOR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 5 10

More info and screens

7

2. Health

2.1 Basic Checks

ETOR has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for ETOR has been reduced compared to a year ago.
ETOR Yearly Shares OutstandingETOR Yearly Shares OutstandingYearly Shares Outstanding 2020 2023 2024 20M 40M 60M 80M
ETOR Yearly Total Debt VS Total AssetsETOR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 20.68 indicates that ETOR is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 20.68, ETOR belongs to the top of the industry, outperforming 98.31% of the companies in the same industry.
ETOR has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
ETOR has a better Debt to Equity ratio (0.05) than 82.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 20.68
ROIC/WACCN/A
WACCN/A
ETOR Yearly LT Debt VS Equity VS FCFETOR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

ETOR has a Current Ratio of 3.76. This indicates that ETOR is financially healthy and has no problem in meeting its short term obligations.
ETOR has a Current ratio of 3.76. This is amongst the best in the industry. ETOR outperforms 83.05% of its industry peers.
ETOR has a Quick Ratio of 3.76. This indicates that ETOR is financially healthy and has no problem in meeting its short term obligations.
ETOR has a better Quick ratio (3.76) than 83.05% of its industry peers.
Industry RankSector Rank
Current Ratio 3.76
Quick Ratio 3.76
ETOR Yearly Current Assets VS Current LiabilitesETOR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1160.60% over the past year.
ETOR shows a strong growth in Revenue. In the last year, the Revenue has grown by 225.39%.
EPS 1Y (TTM)1160.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)225.39%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 9.59% on average over the next years. This is quite good.
ETOR is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -56.73% yearly.
EPS Next Y5.7%
EPS Next 2Y7.71%
EPS Next 3Y9.59%
EPS Next 5YN/A
Revenue Next Year-93.24%
Revenue Next 2Y-72.83%
Revenue Next 3Y-56.73%
Revenue Next 5YN/A

3.3 Evolution

ETOR Yearly Revenue VS EstimatesETOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
ETOR Yearly EPS VS EstimatesETOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 1 2 3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 27.69, ETOR can be considered very expensive at the moment.
Based on the Price/Earnings ratio, ETOR is valued a bit more expensive than 65.68% of the companies in the same industry.
ETOR's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.04.
The Price/Forward Earnings ratio is 23.89, which indicates a rather expensive current valuation of ETOR.
61.44% of the companies in the same industry are cheaper than ETOR, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ETOR to the average of the S&P500 Index (37.64), we can say ETOR is valued slightly cheaper.
Industry RankSector Rank
PE 27.69
Fwd PE 23.89
ETOR Price Earnings VS Forward Price EarningsETOR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

81.36% of the companies in the same industry are more expensive than ETOR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.74
ETOR Per share dataETOR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ETOR does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.86
PEG (5Y)N/A
EPS Next 2Y7.71%
EPS Next 3Y9.59%

More info and screens

0

5. Dividend

5.1 Amount

ETOR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ETORO GROUP LTD-A

NASDAQ:ETOR (7/25/2025, 8:00:01 PM)

After market: 65.5 +0.42 (+0.65%)

65.08

+1.32 (+2.07%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)08-12 2025-08-12
Inst Owners15.71%
Inst Owner ChangeN/A
Ins Owners3.86%
Ins Owner ChangeN/A
Market Cap5.45B
Analysts75.24
Price Target76.3 (17.24%)
Short Float %3.84%
Short Ratio1.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.53%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.92%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 27.69
Fwd PE 23.89
P/S 0.43
P/FCF N/A
P/OCF N/A
P/B 6.09
P/tB 6.42
EV/EBITDA 15.74
EPS(TTM)2.35
EY3.61%
EPS(NY)2.72
Fwd EY4.19%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS151.01
BVpS10.69
TBVpS10.14
PEG (NY)4.86
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 15.32%
ROE 21.5%
ROCE 30.03%
ROIC 20.02%
ROICexc 87.96%
ROICexgc 111.35%
OM 2.26%
PM (TTM) 1.52%
GM 6.52%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover10.07
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA 0.14
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.76
Quick Ratio 3.76
Altman-Z 20.68
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)23.98%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.04%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1160.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y5.7%
EPS Next 2Y7.71%
EPS Next 3Y9.59%
EPS Next 5YN/A
Revenue 1Y (TTM)225.39%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-93.24%
Revenue Next 2Y-72.83%
Revenue Next 3Y-56.73%
Revenue Next 5YN/A
EBIT growth 1Y413.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y140.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y140.16%
OCF growth 3YN/A
OCF growth 5YN/A